Osteopontin (OPN) is typically expressed by bile ducts and can regulate cell proliferation, inflammation, and fibrogenesis, but the impact on NAFLD progression is unknown. This evidence concerns the gene SPP1 and metabolic dysfunction-associated steatotic liver disease.